XML 21 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating activities    
Net income $ 23,708 $ 1,869
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 66,020 63,369
Amortization of items charged to interest expense 1,876 1,505
Change in contingent purchase price (1,201) 351
(Gain) loss on sale of property and equipment and assets held for sale (1,101) 153
Income from unconsolidated affiliates (4,609) (3,982)
Distributions from unconsolidated affiliates 7,400 8,000
Deferred income taxes (740) 18,648
Charge for stock-based compensation 1,455 2,084
(Increase) decrease,    
Accounts receivable (1,803) 727
Prepaid expenses and other current assets (11,579) (2,742)
Other assets 3,039 6,400
(Decrease) Increase,    
Accounts payable (1,951) 2,887
Accrued expenses 648 4,931
Accrued interest 1,550 6,264
Accrued salaries and wages (22,220) (14,363)
Gaming, pari-mutuel, property and other taxes (4,920) 3,754
Income taxes 22,826 (11,738)
Other current and noncurrent liabilities (7,065) (10,081)
Net cash provided by operating activities 71,333 78,036
Investing activities    
Capital project expenditures (6,496) (36,929)
Capital maintenance expenditures (14,873) (11,860)
Advances to the Jamul Tribe (51,781) (16,341)
Proceeds from sale of property and equipment and assets held for sale 2,091 146
Investment in joint ventures   (328)
Acquisition of other property and equipment 148  
Net cash used in investing activities (71,207) (65,312)
Financing activities    
Proceeds from exercise of options 1,742 2,743
Principal payments on financing obligation with GLPI (12,648) (12,475)
Proceeds from issuance of long-term debt, net of issuance costs 12,214 45,000
Principal payments on long-term debt (23,404) (21,886)
Payments of other long-term obligations (6,899)  
Proceeds from insurance financing 9,193 885
Payments on insurance financing (3,784) (4,314)
Tax benefit from stock options exercised 689 6,379
Net cash (used in) provided by financing activities (22,897) 16,332
Net (decrease) increase in cash and cash equivalents (22,771) 29,056
Cash and cash equivalents at beginning of year 237,009 208,673
Cash and cash equivalents at end of period 214,238 237,729
Supplemental disclosure    
Interest expense paid, net of amounts capitalized 113,629 100,179
Income tax (refunds received)/taxes paid $ (12,481) $ 226